Approaches for targeting blood pressure control in sleep disorders

Current Opinion in Nephrology and Hypertension

Volumn 21, Issue 5, 2012, Pages 469-474

  Guralnick, Amy ^a   Bakris, George L ^b  

^a Section of Pulmonary and Critical Care Medicine   (United States)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Blood pressure; Hypertension; Sleep; Sleep apnea

Indexed keywords

ATENOLOL; LOSARTAN; METOPROLOL; PROPRANOLOL; VALSARTAN;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEART RATE; HUMAN; HYPERTENSION; HYPOXIA; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RESISTANT HYPERTENSION; REVIEW; SLEEP APNEA SYNDROME; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; HYPERTENSION; SLEEP DISORDERS; TREATMENT OUTCOME;

EID: 84865419511     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e32835623f5     Document Type: Review

References (41)

1. Sleep related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine Task Force. Sleep 1999; 22:667-689.
2. Young T, Finn L, Peppard PE, et al. Sleep disordered breathing and mortality: eight-year follow-up of the Wisconsin sleep cohort. Sleep 2008; 3:1071-1078.
3. Marshall NS, Wong KK, Liu PY, et al. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008; 31:1079-1085.
4. Fletcher EC, DeBehnke RD, Lovoi MS, Gorin AB. Undiagnosed sleep apnea in patients with resistant hypertension. Ann Intern Med 1985; 103:190-195. (Pubitemid 15000567)
5. Lavie P, Ben-Yosef R, Rubin AE. Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 1984; 108:373-376. (Pubitemid 14061382)
6. Worsnop CJ, Naughton MT, Barter CE, et al. The prevalence of obstructive sleep apnea in hypertensives. Am J Respir Crit Care Med 1998; 157:111-115. (Pubitemid 28071270)
7. Drager LF, Genta RP, Nerbass FB, et al. Characteristics and predictors of obstructive sleep apnea in patients with systemic hypertension. Am J Cardiol 2010; 105:1135-1139.
8. Young T, Peppard P, Palta M, et al. Population-based study of sleep disordered breathing as a risk factor for systemic hypertension. Arch Intern Med 1997; 157:1746-1752. (Pubitemid 27327411)
9. Lavie P, Herer P, Hoffstein V. Obstructive Sleep Apnea syndrome as a risk factor for hypertension population study. BMJ 2000; 320:479-482. (Pubitemid 30173118)
10. Grote L, Hedner J, Peter JH. Sleep related breathing disorder is an independent risk factor for uncontrolled hypertension. Hypertension 2000; 18:679-685. (Pubitemid 30406738)
11. Peppard PE, Young T, PaltaM, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378-1384. (Pubitemid 30262394)
12. O'Connor GT, Caffo B, Newman AB, et al. Prospective study of sleepdisordered breathing and hypertension: the Sleep Heart Health Study. Am J Respir Crit Care Med 2009; 179:1159-1164.
13. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96:1897-1904.
14. Narkiewicz K, Kato M, Phillips BG, et al. Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. Circulation 1999; 100:2332-2335.
15. Tamisier R, Gilmartin GS, Launois SH, et al. A new model of chronic intermittent hypoxia in humans: effect on ventilation, sleep, and blood pressure. J Appl Physiol 2009; 107:17-24.
16. Moller DS, Lind P, Strunge B, Pedersen EB. Abnormal vasoactive hormones and 24-h blood pressure in obstructive sleep apnea. Am J Hypertens 2003; 16:274-280. (Pubitemid 36384754)
17. Giles TL, Lasserson TJ, Smith B, et al. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst Rev 2006:3.
18. Haentjens P, Van Meerhaeghe A, Mascariello A, et al. The impact of continuous positive airway pressure on blood pressure in patients with obstructive sleep apnoea syndrome. Arch Intern Med 2007; 167:757-765.
19. Bradley TD, Floras JS. Obstructive sleep apnoea and its cardiovascular consequences. Lancet 2009; 373:82-93.
20. Wessel N, Suhrbier A, Riedl M, et al. Detection of time-delayed interactions in biosignals using symbolic coupling traces. EPL 2009; 87:10004.
21. Suhrbier A, Riedl M, Malberg H, et al. Cardiovascular regulation during sleep quantified by symbolic coupling traces. Chaos 2010; 20:045124.
22. Penzel T, Riedl M, Gapelyuk A, et al. Effect of CPAP therapy on daytime cardiovascular regulations in patients with obstructive sleep apnea. Comput Biol Med 2012; 42:328-334.
23. Chobanian AV, Bakris GL, Black HR, et al. Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint national Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252. (Pubitemid 37553153)
24. Pickering TG, Eguchi K, Kario K. Masked hypertension: a review. Hypertens Res 2007; 30:479-488. (Pubitemid 47083117)
25. Drager LF, Pedrosa RP, Diniz PM, et al. The effects of continuous positive airway pressure on prehypertension and masked hypertension in men with severe obstructive sleep apnea. Hypertension 2011; 57:549-555.
26. Duran-Cantolla J, Aizpuru F, Montserrat JM, et al. Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomized controlled trial. BMJ 2010; 341:c5991.
27. Zhao Q, Liu ZH, Luo Q, et al. Effects of continuous positive airway pressure on blood pressure and daytime sleepiness in obstructive sleep apnea patients with coronary heart diseases under optimal medications. Sleep Breath 2012; 16:341-347.
28. Jaimchariyatam N, Rodriguez CL, Budur K. Does CPAP treatment in mild obstructive sleep apnea affect blood pressure? Sleep Med 2010; 11:837-842.
29. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
30. Dernaika TA, Kinasewitz GT, Tawk MM. Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 2009; 5:103-107.
31. Logan AG, Perlikowski SM, Mente A, et al. High prevalence of unrecognized sleep apnoea in drug resistant hypertension. J Hypertens 2001; 19:2271-2277. (Pubitemid 33135251)
32. Pratt-Ubunama MN, Nishizaka MK, Boedefeld RL, et al. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest 2007; 131:453-459.
33. Martínez-García MA, Gómez-AldaravíJJ, Soler-Cataluña JJ, et al. Positive effect of CPAP treatment on the control of difficult-to-treat hypertension. Eur Respir J 2007; 29:951-957.
34. Lozano L, Tovar JL, Sampol G, et al. Continuous positive airway pressure treatment in sleep apnea patients with resistant hypertension: a randomized, controlled trial. J Hypertens 2010; 28:2161-2168.
35. Weichler U, Herresmayer B, Mayer J, et al. Influence of antihypertensive drug therapy on sleep pattern and sleep apnea. Cardiology 1991; 78:124-130.
36. Tsioufis C, Kasiakogias A, Thomopoulos C, et al. Managing hypertension in obstructive sleep apnea: the interplay of continuous positive airway pressure, medication and chronotherapy. J Hypertens 2010; 28:875-882.
37. Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol 2000; 119:189-197. (Pubitemid 30155574)
38. Fletcher EC, Bao G, Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 1999; 34:309-314. (Pubitemid 29409233)
39. Pépin JL, Tamisier R, Barone-Rochette G, et al. Comparison of continuous positive airway pressure and valsartan in hypertensive patients with sleep apnea. Am J Respir Crit Care Med 2010; 182:954-960.
40. Bertisch SM, Schomer A, Kelly EE, et al. Device-guided paced respiration as an adjunctive therapy for hypertension in obstructive sleep apnea: a pilot feasibility study. Appl Psychophysiol Biofeedback 2011; 36:173-179.
41. Witkowski A, Prejbisz A, Florczak E, et al. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Hypertension 2011; 58:559-565.